Friday, January 26, 2018


Endo Agrees To Pause Lawsuit After FDA Promises New Bulks Guidance
Endo Pharmaceuticals has agreed to a temporary stay of its lawsuit against FDA over the agency's interim policy on compounding using bulk substances until the agency releases new guidance to significantly rework the controversial policy. As Inside Health Policy previously reported, Endo sued FDA in ...
Post a Comment